Publicacions en què col·labora amb Carla Ferri (12)

2023

  1. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

2022

  1. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

  2. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

2021

  1. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

    Scientific Reports, Vol. 11, Núm. 1

  2. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia

    Rheumatology (Oxford, England), Vol. 60, Núm. 1, pp. 371-379

2020

  1. Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications

    Frontiers in Medicine, Vol. 7

  2. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Fibroblast growth factor 23 expression in human calcified vascular tissues

    Aging, Vol. 11, Núm. 18, pp. 7899-7913

  2. Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

    Journal of Clinical Medicine, Vol. 8, Núm. 3

2018

  1. Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease

    Diabetes Care, Vol. 41, Núm. 8, pp. 1817-1820

2017

  1. Anti-inflammatory profile of paricalcitol in kidney transplant recipients

    Nefrologia, Vol. 37, Núm. 6, pp. 622-629

  2. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease

    Clinical Science, Vol. 131, Núm. 21, pp. 2601-2609